DE69033006T2 - Herstellungsverfahren für ein plasmid mit fähigkeiten zu expression und prozessierung nach translation eines retroviralen gens, so erhaltenes plasmid und dessen expressionsprodukt - Google Patents

Herstellungsverfahren für ein plasmid mit fähigkeiten zu expression und prozessierung nach translation eines retroviralen gens, so erhaltenes plasmid und dessen expressionsprodukt

Info

Publication number
DE69033006T2
DE69033006T2 DE69033006T DE69033006T DE69033006T2 DE 69033006 T2 DE69033006 T2 DE 69033006T2 DE 69033006 T DE69033006 T DE 69033006T DE 69033006 T DE69033006 T DE 69033006T DE 69033006 T2 DE69033006 T2 DE 69033006T2
Authority
DE
Germany
Prior art keywords
plasmid
expression
gene
expression product
abilities
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69033006T
Other languages
English (en)
Other versions
DE69033006D1 (de
Inventor
Atsushi Saito
Naoto Tanaka
Hideo Shinagawa
Atsuo Nakata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation for Microbial Diseases of Osaka University BIKEN
Original Assignee
Research Foundation for Microbial Diseases of Osaka University BIKEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation for Microbial Diseases of Osaka University BIKEN filed Critical Research Foundation for Microbial Diseases of Osaka University BIKEN
Application granted granted Critical
Publication of DE69033006D1 publication Critical patent/DE69033006D1/de
Publication of DE69033006T2 publication Critical patent/DE69033006T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69033006T 1990-05-28 1990-11-30 Herstellungsverfahren für ein plasmid mit fähigkeiten zu expression und prozessierung nach translation eines retroviralen gens, so erhaltenes plasmid und dessen expressionsprodukt Expired - Fee Related DE69033006T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13935890 1990-05-28
PCT/JP1990/001561 WO1991018990A1 (fr) 1990-05-28 1990-11-30 Procede de preparation de plasmide ayant des capacites d'expression et de transformation apres translation d'un gene de retrovirus, plasmide ainsi obtenu, et produit d'expression d'un tel plasmide

Publications (2)

Publication Number Publication Date
DE69033006D1 DE69033006D1 (de) 1999-04-22
DE69033006T2 true DE69033006T2 (de) 1999-09-23

Family

ID=15243470

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69033006T Expired - Fee Related DE69033006T2 (de) 1990-05-28 1990-11-30 Herstellungsverfahren für ein plasmid mit fähigkeiten zu expression und prozessierung nach translation eines retroviralen gens, so erhaltenes plasmid und dessen expressionsprodukt

Country Status (10)

Country Link
US (2) US5610067A (de)
EP (2) EP0867510A1 (de)
JP (1) JP2000189164A (de)
AT (1) ATE177786T1 (de)
AU (1) AU649640B2 (de)
BR (1) BR9007566A (de)
CA (1) CA2059541C (de)
DE (1) DE69033006T2 (de)
HU (1) HUT62654A (de)
WO (1) WO1991018990A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334394A (en) * 1990-06-22 1994-08-02 The Regents Of The University Of California Human immunodeficiency virus decoy
MX9206981A (es) * 1991-12-06 1994-08-31 Whitehead Biomedical Inst Vacunas de recombinantes y metodo para producirlas.
US5965124A (en) * 1991-12-06 1999-10-12 Whitehead Institute For Biomedical Research Replication-competent recombinant viral vaccines and method of producing same
CA2279675A1 (en) 1995-12-15 1997-06-16 Enzo Therapeutics, Inc. Property effecting and/or property exhibiting constructs for localizing a nucleic acid construct within a cell for therapeutic and diagnostic uses
KR100467395B1 (ko) * 1997-03-21 2005-07-12 동아제약주식회사 HIV-1항원p24및gp41의제조방법
CA2324441A1 (en) * 1998-03-27 1999-10-07 Cancer Research Ventures Limited Materials and methods relating to a novel retrovirus
US6406892B1 (en) * 2001-05-23 2002-06-18 Bio-Rad Laboratories, Inc. Acetate-free purification of plasmid DNA on hydroxyapatite
US6964803B2 (en) * 2002-07-26 2005-11-15 Kimberly-Clark Worldwide, Inc. Absorbent structures with selectively placed flexible absorbent binder
US7205259B2 (en) * 2002-07-26 2007-04-17 Kimberly-Clark Worldwide, Inc. Absorbent binder desiccant composition and articles incorporating it
US6737491B2 (en) * 2002-07-26 2004-05-18 Kimberly-Clark Worldwide, Inc. Absorbent binder composition and method of making same
US7115321B2 (en) 2002-07-26 2006-10-03 Kimberly-Clark Worldwide, Inc. Absorbent binder coating
US6887961B2 (en) * 2002-07-26 2005-05-03 Kimberly-Clark Worldwide, Inc. Absorbent binder composition and method of making it
WO2005070041A2 (en) * 2004-01-09 2005-08-04 Morehouse School Of Medicine Modulating vaccine against hiv nef protein-induced lymphocyte depletion
US8007538B2 (en) * 2005-02-25 2011-08-30 Shoulder Innovations, Llc Shoulder implant for glenoid replacement
US20070083175A1 (en) * 2005-10-11 2007-04-12 Kimberly-Clark Worldwide, Inc. Transparent/translucent absorbent composites and articles
US7619131B2 (en) 2005-12-02 2009-11-17 Kimberly-Clark Worldwide, Inc. Articles comprising transparent/translucent polymer composition
US7335713B2 (en) 2005-12-02 2008-02-26 Stockhausen, Inc. Method for preparing a flexible superabsorbent binder polymer composition
US20070129697A1 (en) * 2005-12-02 2007-06-07 Soerens Dave A Articles comprising flexible superabsorbent binder polymer composition
US7312286B2 (en) * 2005-12-02 2007-12-25 Stockhausen, Inc. Flexible superabsorbent binder polymer composition
KR102014518B1 (ko) * 2017-01-05 2019-08-26 서울대학교산학협력단 HIV 1의 p24 단백질을 발현하는 벡터가 도입된 재조합 마이코박테리움 스메그마티스 균주 및 이를 포함하는 백신

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8314362D0 (en) * 1983-05-24 1983-06-29 Celltech Ltd Polypeptide and protein products
AU6713287A (en) * 1986-01-06 1987-07-09 F. Hoffmann-La Roche & Co. Expression of htlv-iii gag-gene
FR2600079B1 (fr) * 1986-06-16 1989-10-20 Transgene Sa Vecteur viral et adn recombinant codant pour la proteine f du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la proteine, proteine obtenue, vaccin et anticorps obtenus
DE3724016A1 (de) * 1987-07-21 1989-02-02 Hans Prof Dr Dr Wolf Methoden fuer die gentechnologische produktion von antigenen sowie deren nutzung in einem neuen ansatz fuer bestaetigungsteste fuer antikoerper am beispiel des humanen immundefizienz-virus (hiv)
HU209835B (en) * 1988-12-07 1994-11-28 Univ Osaka Res Found Method for producing of retrovirus protease, reverse transcriptase and integrase

Also Published As

Publication number Publication date
WO1991018990A1 (fr) 1991-12-12
EP0485611A4 (en) 1993-09-22
HU9200260D0 (en) 1992-06-29
BR9007566A (pt) 1992-06-30
US6020171A (en) 2000-02-01
US5610067A (en) 1997-03-11
HUT62654A (en) 1993-05-28
JP2000189164A (ja) 2000-07-11
AU6877091A (en) 1991-12-31
EP0867510A1 (de) 1998-09-30
CA2059541C (en) 1996-06-04
CA2059541A1 (en) 1991-11-29
DE69033006D1 (de) 1999-04-22
AU649640B2 (en) 1994-06-02
EP0485611A1 (de) 1992-05-20
ATE177786T1 (de) 1999-04-15
EP0485611B1 (de) 1999-03-17

Similar Documents

Publication Publication Date Title
DE69033006D1 (de) Herstellungsverfahren für ein plasmid mit fähigkeiten zu expression und prozessierung nach translation eines retroviralen gens, so erhaltenes plasmid und dessen expressionsprodukt
YU45534B (en) Process for the production of a polypeptide article by means of the expression of a structural gene which codes it in bacteria
ES8607391A1 (es) Procedimiento para producir un fragmento de dna que compren-de un promotor de fosfatasa acida de levadura
ES8504937A1 (es) Un metodo de producir polipeptidos similares a la hormona del crecimiento porcina.
DE68906883T2 (de) Verfahren und Apparat für die Herstellung und Verflüssigung von Gasen.
DE69013811D1 (de) Verfahren zur Herstellung von antiviralem Protein unter Benützung von E.coli-Transformant, das Gen, das für dieses Protein kodiert und E.coli-Vektor benützt in diesem Verfahren.
DE69105352D1 (de) Koformungsapparat für eine Maschine zur Herstellung von Nahrungsmittelprodukten.
SG47515A1 (en) Plant gum material and use thereof in food products
FR2545099B1 (fr) Nouvelle souche de trichoderma harzianum procede d'isolement de cette souche, procede de culture de cette souche, nouveaux peptides produits par cette souche, et application de cette souche et ces nouveaux peptides ou du produit obtenu par le procede de culture comme moyen de lutte biologique sous forme de produit phytosanitaire
GB8927048D0 (en) Dna,constructs,cells and plants derived therefrom
DK0387646T3 (da) Achromobacter-protease I-gen og genprodukt deraf
AU3678789A (en) Process for preparing human factor viii:c employing expression vector containing chick beta-actin promoter
MY103364A (en) Synthetic porcine growth hormone
DE3787044T2 (de) Transformant einer tierischen Zelle, Verfahren zur Herstellung des Transformanten und dessen Verwendung zur Präparation eines gewünschten Fremdgenproduktes.
CA2102043A1 (en) Mutant aox2 promoter, vector carrying same, transformant, and production of heterologous protein
HUT60326A (en) Process for producing lesion-induced dna deriving from solanum tuberosum
DE3788592T2 (de) Plasmidvektor zur Expression im Bazillus, dessen Umwendung für die Klonierung des menschlichen Wachstumshormongens und Verfahren zur Produktion des Hormons.
ATE188997T1 (de) Klonierung von malaria-spezifischen dna- sequenzen:isolierung des gens für das 140 kd protein
AU2268988A (en) Acid proteinic concentrate obtained from milk, process for its production and its use in cheese making
DE3486163T2 (de) Plasmide, Verfahren zu ihrer Herstellung, sie enthaltende Mikroorganismen und Methoden zur extrazellulären Herstellung von Xylanase durch Züchten dieser Mikroorganismen.
DE3883155T2 (de) Sintererzeugnis von hoher Festigkeit und Zähigkeit und Verfahren zu seiner Herstellung.
Asao et al. Prospects for Future and Present Dieless Forming
ATE84395T1 (de) Verfahren zur herstellung von kaese und so hergestellter kaese.
Chandler An Update: What Users Should Know About Clean Steel Technology
TROJE et al. PRODUCTION MONITORING BY SIMPLE MEANS. PRACTICAL EXPERIENCE AND BENEFITS

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee